Published guidance, NICE advice and quality standards

Showing 61 to 70 of 1851

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)	TA940	20 December 2023	20 December 2023
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)	TA941	20 December 2023	20 December 2023
Empagliflozin for treating chronic kidney disease	TA942	20 December 2023	20 December 2023
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes	TA943	19 December 2023	19 December 2023
Risdiplam for treating spinal muscular atrophy	TA755	16 December 2021	15 December 2023
Digitally enabled therapies for adults with anxiety disorders: early value assessment	HTE9	16 May 2023	14 December 2023
Middle meningeal artery embolisation for chronic subdural haematomas	IPG779	14 December 2023	14 December 2023
Cardiovascular disease: risk assessment and reduction, including lipid modification	NG238	14 December 2023	14 December 2023
Velmanase alfa for treating alpha-mannosidosis	HST29	13 December 2023	13 December 2023
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer	TA939	13 December 2023	13 December 2023